Our Plan B is to invest in the #art & #science of #cooking and #food preparation! Fantastic “Fall 2022 Cookoff” for Singh Lab at Georgia Tech. Some serious talent in lab! The F22 winner is Kathryn Castro-Quilang (receiving the trophy 🏆 from last year’s winner Valeria Montserrat Juarez)! Institute for Bioengineering and Bioscience @ GT

Thrilled to share our work in Nature Materials on profiling lymphoid tumor microenvironment & engineering Lymphoma organoids to define complex cell-TME crosstalks! Huge congrats to my PhD Shiv Shah & all collabs!! Thx NIH Wellcome Leap HOPE for support! nature.com/articles/s4156…

New treatments for a specific kind of lymphoma have shown promise, but 3 in 5 patients aren’t responding well in trials. Ankur Singh's team developed a synthetic tumor model to see why & their work could help deliver on the promises of precision medicine: b.gatech.edu/3G31swq

Groundbreaking bioengineered technologies developed by Singh Lab at Georgia Tech that model the lymphoid tumor microenvironment and enable further development of targeted cancer therapies👏

Looking forward to attending the Health Disparities in Hematologic Malignancies' conference this May in NYC!💃

It’s #glycotime when Carolyn Bertozzi tweets about your research!! Thank you!! Shiv Shah Singh Lab at Georgia Tech Matthew DeLisa Ty Moeller!

Making history! Coulter BME | Emory & Georgia Tech ranks #⃣1⃣ in nation among graduate biomedical engineering programs in the nation! First time ever in program history. U.S. News & World Report Georgia Tech College of Engineering Go Jackets! 🐝🐝🐝 Read more: bit.ly/3VduwaT

Excited to be back in NYC! Great start of “Health Disparities in Hematologic Malignancies: From Genes to Outreach” meeting with 2 of my fav people in lymphoma research - Chris Flowers & Ari Melnick! Looking fwd to presenting our lab’s research in lymphoma & health disparities!

Solid organ or hematopoietic stem cell transplant patients are at high risk for developing post-transplant lymphoproliferative disorder (PTLD). We share our clinical & treatment perspective, led by Dr @JeanKoffMD, Dr Michelle J Lee, Deepali Balasubramani et al. link.springer.com/article/10.100…

I had a fantastic time at the Health Disparities in Hematologic Malignancies conference in NYC, attending talks and networking with leading experts in various aspects of this field from genomics, disease modeling , local/international outreach, and social determinants of health!

Bou Samnang, a Cambodian runner, had low blood pressure during the 5,000 meters at the Southeast Asian Games. She was last by a wide margin. She was being soaked by a rainstorm. Her determination to finish the race anyway won her nation’s heart. nyti.ms/3OEE1yr

Spotlight on one of IBB's centers: the NIH has renewed its first T32 Research Program in ImmunoEngineering to help train the next generation of leaders in ImmunoEngineering! Full story here: immunoengineering.gatech.edu/nih-renews-nat… #IBB #immunoengineering

Exciting times! Highly motivated trainees are pushing new research boundaries in lab! U.S. National Science Foundation GRFP lucy britto ツ & NIBIB Immunoengineering T32 trainee Deepali Balasubramani are developing innovative #imaging approaches to study #immune regulations in B cell #lymphomas! Stay tuned!!

The T cell repertoire in lab is expanding and diversifying! Join us!

Congrats to my Georgia Tech ME PhD student Zhe Monica Zhong on receiving a '24 GT NEXT Award for engineering the human immune system. The Georgia Tech Office of Technology Licensing award celebrates inventiveness for advancements that contribute significantly to the betterment of society. commercialization.gatech.edu/gt-next-award-…

This morning, our immunoengineering group had a Immunoengineering Trainee Seminar, with presentations from two Ph.D. students! 🔬 #IBB #immunoengineering

🎉Huge congrats to my PhD student, Deepali Balasubramani (Deepali Balasubramani), on receiving a prestigious NIH T32 ImmunoEngineering fellowship!🏅Deepali is driving innovation @ the intersection of health disparity, cancer, & immunoengineering, in collab w/ @JeanKoffMD. So proud! 👋🏼

For the 1st time, we can recreate & sustain “complex human immunological processes” in a synthetic gel; gamechanger for understanding & treating immune vulnerabilities in cancer patients who have undergone treatment. Thx CB for news coverage 🙌🏽! 👉🏽 research.gatech.edu/lab-grown-huma…

Pleased to share our new work Science Advances, led by Zhu Lab @GeorgiaTech, revealing how forces regulate B cell & T cell synapse interactions. Our findings shed light on mechanistic underpinnings underlying the pathology of #immunodeficiencies, X-HIgM syndrome. science.org/doi/10.1126/sc…

Some diffuse large B-cell lymphoma (DLBCL) patients—specifically African American patients and those with Epstein-Barr virus (EBV)—face worse outcomes. Backed by an LLS-funded grant, Dr. Jean Koff from Winship Cancer Institute of Emory University is working to change that 👉 bit.ly/411z2N7